Is it appropriate to treat a pregnant woman with an asymptomatic Streptococcus gallolyticus (formerly Streptococcus bovis) urinary isolate using amoxicillin? | Rounds Is it appropriate to treat a pregnant woman with an asymptomatic Streptococcus gallolyticus (formerly Streptococcus bovis) urinary isolate using amoxicillin? | Rounds
Loading...

Is it appropriate to treat a pregnant woman with an asymptomatic Streptococcus gallolyticus (formerly Streptococcus bovis) urinary isolate using amoxicillin?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Asymptomatic bacteriuria in pregnancy requiring antibiotic therapy

Treatment of asymptomatic bacteriuria in pregnancy is recommended. [1] An antibiotic selected to which the cultured organism is susceptible is appropriate. [2] Amoxicillin is appropriate for asymptomatic bacteriuria in pregnancy when susceptibility testing supports its use. [1], [2]

Treatment eligibility and when antibiotics are indicated

In pregnant women with asymptomatic bacteriuria, antimicrobial therapy is recommended. [1] Asymptomatic bacteriuria is defined as significant bacteriuria in the absence of urinary symptoms or systemic features. [2] Treatment is not recommended for non-pregnant patients with asymptomatic bacteriuria. [1]

Medication selection algorithm

Antimicrobial selection for pregnancy should be based on urine culture and susceptibility results. [2] Preferred pregnancy-safe β-lactam options include ampicillin-class agents when susceptibility supports use. [1]

Monotherapy versus combination therapy

Monotherapy with a single agent is recommended for asymptomatic bacteriuria in pregnancy when susceptibility supports the selected agent. [1] Combination therapy is not recommended for routine asymptomatic bacteriuria treatment. [1]

Key evidence supporting therapy in pregnancy

Antimicrobial treatment of asymptomatic bacteriuria in pregnancy reduces pyelonephritis risk, based on older randomized trials summarized in the IDSA guideline. [1] In those trials, antimicrobial therapy decreased pyelonephritis incidence from 20%–35% to 1%–4%. [1] Antimicrobials probably reduce preterm birth risk and may reduce low birth weight risk in pregnancy, based on evidence summarized in the IDSA guideline. [1]

Initiation thresholds and duration

Antibiotic therapy should be initiated after asymptomatic bacteriuria is confirmed in pregnancy. [1] For pregnant women with asymptomatic bacteriuria, a 4–7 day course is recommended over shorter duration regimens. [1]

Common pitfalls to avoid

Empiric use of an agent with likely resistance should be avoided when culture and susceptibility testing are available. [2] Delayed culture-directed adjustment after treatment initiation should be avoided because agent selection is susceptibility-dependent. [2]

Targets and goals of therapy

The goal is eradication of bacteriuria and prevention of progression to pyelonephritis and associated adverse pregnancy outcomes. [1]

Direct answer to the case question

Amoxicillin treatment is appropriate for a pregnant patient with asymptomatic Streptococcus gallolyticus urinary isolate only when susceptibility testing shows the organism is susceptible to amoxicillin (amoxicillin is a β-lactam option used when susceptibility supports β-lactam therapy). [1], [2]

Related Questions